The difference at the later time-point can be attributed to CD34 loss on hematopoietic cells and likely reflects a reduced capacity of Cd34−/− mast cells and eosinophils to dampen tumor growth and induce immune tumor rejection. Here, CD34 is linked to neoplasm.